dr. mcintyre on a phase ii study analyzing first-line eribulin mesylate
Published 10 years ago • 76 plays • Length 1:17Download video MP4
Download video MP3
Similar videos
-
1:00
dr. mcintyre on eribulin as first-line therapy in her2- breast cancer
-
6:51
treatment with eribulin mesylate in metastatic breast cancer
-
1:23
joyce o’shaughnessy, md: different mechanisms of action in eribulin
-
2:53
meet ben heyman, md: hematologist
-
1:11
joyce o’shaughnessy, md: candidacy for eribulin therapy
-
1:11
joyce o’shaughnessy, md: candidacy for eribulin therapy
-
0:31
dr. eng: re-initiating bevacizumab after multiple lines of treatment
-
3:40
treatment with eribulin in metastatic breast cancer
-
1:05
dr. balar on phase iii assure trial results for rcc
-
1:42
dr. mcdermott on immotion150 trial in rcc
-
4:27
intensive exercise and renal medullary carcinoma: is there a connection?
-
2:41
assessing the side effects of milademetan
-
0:34
dr. eng: second-line options to prolong survival
-
8:03
progress in first-line mrcc
-
1:01
dr. mcdermott on lessons from the immotion150 trial in rcc
-
0:47
remaining areas of unmet need for patients with locally advanced pancreatic cancer
-
1:08
dr. mcgregor on unmet needs in non-clear cell rcc
-
2:58
a case of mtc features and spindle cells
-
6:33
case 3: results of the impassion130 trial in metastatic breast cancer